Clinical evaluation of the first oxycodone once daily prolonged release tablet in moderate to severe chronic pain: a randomized, double-blind, multicenter, cross-over, non-inferiority study to investigate efficacy and safety in comparison with an established oxycodone twice daily prolonged release tablet

Lux Eberhard Albert; Janecki Marcin; Maritz Martina Alice

首页> 外文期刊>Current medical research and opinion >Clinical evaluation of the first oxycodone once daily prolonged release tablet in moderate to severe chronic pain: a randomized, double-blind, multicenter, cross-over, non-inferiority study to investigate efficacy and safety in comparison with an established oxycodone twice daily prolonged release tablet

【24h】

Clinical evaluation of the first oxycodone once daily prolonged release tablet in moderate to severe chronic pain: a randomized, double-blind, multicenter, cross-over, non-inferiority study to investigate efficacy and safety in comparison with an established oxycodone twice daily prolonged release tablet

机译：首个羟考酮每日一次缓释片在中度至重度慢性疼痛中的临床评估：一项随机，双盲，多中心，交叉，非劣效性研究，与既定的羟考酮每日两次缓释比较，以研究疗效和安全性片剂

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective:

机译：目的：

著录项

来源
《Current medical research and opinion》 |2014年第11期|共11页
作者
Lux Eberhard Albert; Janecki Marcin; Maritz Martina Alice;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医药、卫生;
关键词
Chronic pain; New once daily prolonged release tablet formulation; Oxycodone;

机译：慢性疼痛;每天一次的新的缓释片剂;羟考酮;
入库时间 2022-08-18 09:45:57

相似文献

外文文献
中文文献
专利

1. 羟考酮/纳洛酮控释片与羟考酮控释片治疗韩国癌性疼痛患者的疗效及安全性的随机对照研究 [J] . Kyung-He Lee, Min Kyoung Kim, Yong Sang Hong, 癌症（英文版） . 2018,第005期
2. Clinical evaluation of the first oxycodone once daily prolonged release tablet in moderate to severe chronic pain: a randomized, double-blind, multicenter, cross-over, non-inferiority study to investigate efficacy and safety in comparison with an established oxycodone twice daily prolonged release tablet [J] . Lux Eberhard Albert, Janecki Marcin, Maritz Martina Alice Current medical research and opinion . 2014,第11期

机译：首个羟考酮每日一次缓释片在中度至重度慢性疼痛中的临床评估：一项随机，双盲，多中心，交叉，非劣效性研究，与既定的羟考酮每日两次缓释比较，以研究疗效和安全性片剂
3. Clinical Efficacy and Safety of Once-Daily Dosing of a Novel, Prolonged-Release Oral Morphine Tablet Compared With Twice-Daily Dosing of a Standard Controlled-Release Morphine Tablet in Patients With Cancer Pain: A Randomized, Double-Blind, Exploratory Cr [J] . Derry Ridgway, Maciej Sopata, Arvydas Burneckis, Journal of pain and symptom management. . 2010,第4期

机译：每日两次新型，延长剂量口服吗啡片与标准控释吗啡片剂两次每日给药对癌痛的临床疗效和安全性：随机，双盲，探索性Cr
4. Efficacy and safety of tapentadol prolonged release for moderate-to-severe chronic osteoarthritis knee pain: a pooled analysis of two double-blind, randomized, placebo- and oxycodone controlled release-controlled studies [J] . Lange Bernd, von Zabern Detlef, Elling Christian, Current medical research and opinion . 2017,第8期

机译：Tabentadol的疗效和安全性延长释放中度至严重的慢性骨关节炎膝关节疼痛：两种双盲，随机，安慰剂和羟考酮控制释放控制研究的合并分析
5. A randomized double-blind non-inferiority study of hydromorphone hydrochloride immediate-release tablets versus oxycodone hydrochloride immediate-release powder for cancer pain: efficacy and safety in Japanese cancer patients [O] . Satoshi Inoue, Yoji Saito, Satoru Tsuneto, -1

机译：盐酸氢吗啡酮速释片与盐酸羟可待酮速释粉对癌症疼痛的随机双盲非劣效性研究：对日本癌症患者的疗效和安全性
6. A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate/severe, chronic cancer pain [O] . Ahmedzai S.H., Nauck F., Bar-Sela G., 2012

机译：一项随机，双盲，主动控制，双模拟，平行组研究，以确定羟考酮/纳洛酮缓释片对中度/重度慢性癌症疼痛患者的安全性和有效性

摘要

著录项

相似文献

相关主题

期刊订阅